Skip to Content

Leukemia, Acute Lymphocytic (ALL), Adolescent & Young Adult (ACCL16N1CD)

Documentation and Delivery of Guideline- Consistent Treatment in Adolescent and young Adult (AYA) Acute Lymphoblastic Leukemia



This research trial studies cancer care delivery in adolescent and young adult patients with acute lymphoblastic leukemia. Surveying institutions, evaluating delivery of care at the patient level and seeking input from healthcare providers may help doctors increase rates of adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines. It may also improve care for adolescent and young adult patients with acute lymphoblastic leukemia.

Key Inclusion Criteria

Inclusion Criteria:

  • Newly diagnosed with either Ph- or Ph+ ALL between January 1st, 2012 and December 31st, 2016
  • Both diagnosed and initially treated at the participating National Cancer Institute Community Oncology Research Program (NCORP) institution during induction and post-induction therapy (PIT)
  • Aim 3: Healthcare professional currently employed at a participating NCORP institution

    • Eligible healthcare providers include but are not limited to: physicians, registered nurses (RNs), nurse practitioners, physician assistants, patient advocates, social workers, pharmacists and clinical research associates (CRAs)
  • Aim 3a: Direct involvement in the care of AYA ALL patients

Key Exclusion Criteria

Phase: III

Exclusion Criteria:

  • Diagnosis of secondary ALL
  • Diagnosis of mixed lineage acute leukemia
  • Diagnosis of acute leukemia of ambiguous lineage (ALAL)
  • Diagnosis of Burkitt?s leukemia
  • Transfer of care to another institution during induction or post-induction therapy (PIT)
  • Aim 3: Trainee

Learn More


IRB Protocol Number
Principal Investigator(s)
Roberto Ferro, MD

Clinical Trial Categories

  • Cancer Care Delivery Research (CCDR)
  • Oncology
  • Hematologic Cancer
Children's Oncology Group
Kelsey Bridges at 864-560-1019
How to Participate

Kelsey Bridges
864-560-1019 or 864-560-6812

Was this page helpful?


Thank you for your feedback!

Thank you for your feedback and helping us to improve our website.
There will be no additional response.

News & Highlights

Stay Connected!

Get the latest news on the health topics that matter most to you.

Sign up